Mobix Labs
Mobix Labs' revenue rose 53.9% to $10 million in fiscal 2025. Its operating margin was −380.3%, up from −720.2% a year earlier. Free cash flow was −$10 million. The diluted share count rose 54.2%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Income statement
Mobix Labs lost money in fiscal 2025: a net loss of $46 million.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY22 | FY24 | FY25 |
|---|---|---|---|
| Cash and short-term investments | 0 | 0 | 3 |
| Debt incl. finance leases | — | 3 | 6 |
| Net debt (negative means net cash) | — | 3 | 3 |
| Net debt to EBITDA | — | — | — |
| Debt to equity | — | 0.6x | — |
| Interest coverage | — | −29.3x | −16.2x |
| Current ratio | 0.2x | 0.2x | 0.2x |
| Quick ratio | 0.2x | 0.1x | 0.2x |
Cash flow
Projections
Project Mobix Labs' revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
Insider trades
Over the 12 months between November 20, 2025 and November 19, 2026, no insider bought Mobix Labs shares on the open market, and 3 insiders sold $396,299.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jul 16, 2026 | Philip SansoneChief Executive Officer, Director | Sold | 9,301 | $1.87 | $17,393 | Form 4 |
| Jun 12, 2026 | Keyvan SaminiPresident, CFO & Director, Director | Sold | 112,110 | $1.98 | $221,978 | Form 4 |
| Jun 11, 2026 | Keyvan SaminiPresident, CFO & Director, Director | Sold | 3 | $2.14 | $6 | Form 4 |
| Apr 30, 2026 | Philip SansoneChief Executive Officer, Director | Sold | 9,541 | $2.35 | $22,421 | Form 4 |
| Feb 2, 2026 | Philip SansoneChief Executive Officer, Director | Sold | 87,025 | $0.19 | $16,535 | Form 4 |
| Jan 5, 2026 | Keyvan SaminiPresident, CFO & Director, Director | Sold | 211,672 | $0.32 | $67,735 | Form 4 |
| Nov 21, 2025 | Philip SansoneChief Executive Officer, Director | Sold | 100,044 | $0.41 | $41,018 | Form 4 |
| Nov 21, 2025 | James AralisChief Technology Officer | Sold | 22,470 | $0.41 | $9,213 | Form 4 |
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY24 | FY25 |
|---|---|---|
| Piotroski F-score | — | — |
| Rule of 40 | — | −48.4% |
| Altman Z'' | −20.01 | −23.79 |
| Accruals ratio | — | −94.5% |
The nine F-score tests
| Test | FY24 | FY25 |
|---|---|---|
| Net income is positive | — | Fail |
| Cash from operations is positive | Fail | Fail |
| Return on assets rose | — | — |
| Cash from operations exceeds net income | Pass | Pass |
| Debt fell relative to assets | — | — |
| Current ratio rose | — | Pass |
| Share count didn't rise | — | Fail |
| Gross margin rose | — | Pass |
| Revenue rose relative to assets | — | — |
| F-score | — | — |
Compare
Put Mobix Labs side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Mobix Labs | FY25 | 53.9% | −380.3% | −102.3% | −528.8% | — | — | |
| Energous | FY25 | 633.1% | −177.9% | −222.1% | — | — | — | Compare |
| SEALSQ | FY25 | 66.2% | −218.1% | −175.3% | — | — | — | Compare |
| Aeluma | FY26 | −4.4% | −228.3% | −87.7% | — | — | — | Compare |
| GSI Technology | FY26 | 22.4% | −69.6% | −65.3% | — | — | — | Compare |
3 years of figures
| Fiscal year | FY22 | FY24 | FY25 |
|---|---|---|---|
| Income statement | |||
| Revenue | — | 6 | 10 |
| Revenue growth | — | — | 53.9% |
| Gross profit | — | 3 | 5 |
| Research and development | — | 6 | 2 |
| Operating income | −1 | −46 | −38 |
| Net income | −1 | −20 | −46 |
| Diluted EPS (US$) | — | −0.75 | −1.01 |
| Diluted shares (millions) | 5 | 30 | 46 |
| Cash flow | |||
| Cash from operations | −0 | −18 | −10 |
| Capital expenditure | — | 0 | 0 |
| Free cash flow | — | −18 | −10 |
| Dividends paid | 0 | 0 | 0 |
| Share buybacks | 0 | 0 | 0 |
| Acquisitions | 0 | 1 | 0 |
| Stock-based compensation | — | 21 | 26 |
| Balance sheet at fiscal year end | |||
| Cash and short-term investments | 0 | 0 | 3 |
| Debt incl. finance leases | — | 3 | 6 |
| Total assets | 10 | 39 | 37 |
| Total liabilities | 2 | 34 | 37 |
| Shareholders' equity | −2 | 6 | −0 |
| Margins and ratios | |||
| Gross margin | — | 39.6% | 50.5% |
| Operating margin | — | −720.2% | −380.3% |
| Net margin | — | −311.0% | −465.4% |
| Free cash flow margin | — | −286.1% | −102.3% |
| Rule of 40 (growth + FCF margin) | — | — | −48.4% |
| Return on capital | — | — | −528.8% |
| Return on equity | — | — | −1,776.3% |
| Return on assets | — | — | −121.1% |
| Net debt to EBITDA | — | — | — |